Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer (vol 12, 125, 2019)

被引：0
|
作者：
Wu, Huan [1 ,2 ]
Li, Rongrong [1 ,2 ]
Zhang, Zhiwei [1 ,2 ]
Jiang, Huiyang [1 ,2 ]
Ma, Hanlin [1 ,2 ]
Yuan, Cunzhong [1 ,2 ]
Sun, Chenggong [1 ,2 ]
Li, Yingwei [1 ,2 ]
Kong, Beihua [1 ,2 ]
机构：
[1] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Shandong Key Lab Gynecol Oncol, Jinan, Shandong, Peoples R China
来源：
JOURNAL OF OVARIAN RESEARCH | 2020年 / 13卷 / 01期
关键词：
D O I：
10.1186/s13048-020-00628-5
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The original article [1] contains errors in Fig. 3C, Results and Discussion.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
    Liu, Huiping
    Zhou, Ling
    Cheng, Hongyan
    Wang, Shang
    Luan, Wenqing
    Cai, E.
    Ye, Xue
    Zhu, Honglan
    Cui, Heng
    Li, Yi
    Chang, Xiaohong
    CHINESE MEDICAL JOURNAL, 2023, 136 (24) : 2974 - 2982
  • [42] Drugs Repurposing in High-Grade Serous Ovarian Cancer
    Torralba, Manuel
    Farra, Rossella
    Maddaloni, Marianna
    Grassi, Mario
    Dapas, Barbara
    Grassi, Gabriele
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) : 7222 - 7233
  • [43] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xia Xu
    Yan Wang
    Fang Wang
    Lizhou Jia
    Yiqin Zhou
    Fei Deng
    Junwei Qu
    Bifang Zhou
    Aifeng Meng
    Bole Fu
    Xiaoxiang Chen
    Zhiying Qian
    Jinhua Wang
    Journal of Ovarian Research, 6
  • [44] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xu, Xia
    Wang, Yan
    Wang, Fang
    Jia, Lizhou
    Zhou, Yiqin
    Deng, Fei
    Qu, Junwei
    Zhou, Bifang
    Meng, Aifeng
    Fu, Bole
    Chen, Xiaoxiang
    Qian, Zhiying
    Wang, Jinhua
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [45] Genome-wide CRISPRi screening reveals determinants of platinum sensitivity and resistance in high-grade serous ovarian cancer
    Kong, Yi Wen
    Handly, Erika D.
    Lu, Robin A.
    Bird, Molly A.
    Schilling, Hannah-Lou
    Yaffe, Samkyu P.
    Yaffe, Michael B.
    Koch, David H.
    CANCER RESEARCH, 2024, 84 (05)
  • [46] DCLK1 mediates tumor stemness and platinum resistance in high-grade serous epithelial ovarian cancer.
    Moxley, Katherine M.
    Ha, JiHee
    Andrade, Daniel
    Houchen, Courtney
    Dhanasekaran, Danny
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 66 - 67
  • [47] Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    Cocchi, Sara
    Lopacinska-Jorgensen, Joanna
    Hogdall, Estrid, V
    ANTICANCER RESEARCH, 2024, 44 (11) : 4691 - 4707
  • [48] Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
    Abdallah, Reem
    Atallah, David
    Bitar, Nizar
    Chahine, Georges
    Ghanem, Hady
    Ghosn, Marwan
    Kattan, Joseph
    Nasr, Fadi
    Makdessi, Joseph
    Shamseddine, Ali
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 47
  • [49] Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Matsuzaki, Juntaro
    Yoshida, Kosuke
    Yamamoto, Yusuke
    Kato, Tomoyasu
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    CANCER MEDICINE, 2024, 13 (22):
  • [50] Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
    Tan, Jiahong
    Song, Chunyan
    Wang, Daoqi
    Hu, Yigang
    Liu, Dan
    Ma, Ding
    Gao, Qinglei
    BIOSCIENCE REPORTS, 2021, 41 (05)
12345